PRESS RELEASE published on 11/25/2025 at 15:48, 11 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.68% ownership in Qualcomm Incorporated. Recent dealings include purchases and sales of USD 0.0001 common securities Securities Dealings Vanguard Group Ownership Disclosure Stock Transactions Qualcomm Incorporated
BRIEF published on 11/25/2025 at 15:47, 11 months 14 days ago The Vanguard Group, Inc. Discloses Position in Mural Oncology plc Ordinary Shares Irish Takeover Panel Securities Disclosure Vanguard Mural Oncology
PRESS RELEASE published on 11/25/2025 at 15:47, 11 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.47% ownership in American Axle & Manufacturing Holdings, Inc. as of 24 November 2025 The Vanguard Group Ownership Disclosure Financial Investment Stock Holdings American Axle & Manufacturing Holdings
BRIEF published on 11/25/2025 at 15:46, 11 months 14 days ago The Vanguard Group Discloses Position in Greencore Group plc Position Disclosure The Vanguard Group Takeover Code Securities Transactions Greencore Group
PRESS RELEASE published on 11/25/2025 at 15:46, 11 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.06% stake in JTC plc as of 24 Nov 2025. Details include owning 8,696,122 relevant securities and recent purchase/sale transactions Relevant Securities The Vanguard Group Stake Disclosure JTC Plc Purchase/sale Transactions
BRIEF published on 11/25/2025 at 15:45, 11 months 14 days ago The Vanguard Group Discloses Position in Spire Healthcare Group Form 8.3 Stock Trading Financial Disclosure Spire Healthcare Vanguard
PRESS RELEASE published on 11/25/2025 at 15:44, 11 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.72% stake in Avadel Pharmaceuticals plc as of 24 Nov 2025. Details on securities ownership and derivatives The Vanguard Group, Inc. Stake Disclosure Securities Ownership Derivatives Avadel Pharmaceuticals Plc
BRIEF published on 11/25/2025 at 15:44, 11 months 14 days ago Vanguard's Disclosure on Alphawave IP Group and Qualcomm Takeover Code Securities Disclosure Vanguard Group Qualcomm Alphawave IP
BRIEF published on 11/25/2025 at 15:42, 11 months 14 days ago The Vanguard Group Discloses Significant Stake in Dowlais Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Dowlais Group
PRESS RELEASE published on 11/25/2025 at 15:42, 11 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.41% interest in Mural Oncology plc as of 24 Nov 2025. No other disclosures made Irish Takeover Panel The Vanguard Group Financial Disclosure Interest Disclosure Mural Oncology Plc
Published on 11/10/2026 at 08:00, 2 hours 2 minutes ago PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 7 hours 17 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 10 hours 52 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 11 hours 2 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 11 hours 30 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/10/2026 at 09:45, 17 minutes ago TRATON GROUP’s International Motors receives U.S. content approval from U.S. Department of Commerce
Published on 11/10/2026 at 09:15, 47 minutes ago AssureTrace Appoints Graham Clark as Business Director and Chief Revenue Officer
Published on 11/10/2026 at 09:05, 57 minutes ago Cepheid Achieves CE Marking Under IVDR for Xpert® Respiratory Panel
Published on 11/10/2026 at 09:05, 57 minutes ago Jackery Black Friday 2026: Up to 58% Off Explorer v2 Portable Power Stations and Solar Generators, Starting at Just £378
Published on 11/10/2026 at 07:00, 3 hours 2 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 15 hours 32 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:35, 16 hours 27 minutes ago Disclosure of transactions in own shares from November 2 to November 6, 2026
Published on 11/09/2026 at 10:32, 23 hours 30 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
